← Back to Nuqta Atlas
Editorially curated · sa-sbipsc
Saudi Bank of Induced Pluripotent Stem Cells
Creates disease-specific Saudi iPSC lines and a population-matched HLA-homozygous cell bank for functional genomics and regenerative therapies.
01 / Project overview
What the record establishes.
- Geographic scope
- Saudi rare/common disease patients and HLA-selected healthy donors
- Project type
- National cell bank and functional-genomics resource
- Research domain
- Regenerative medicine, disease modeling and population immunogenetics
- Years
- 2021–
- Lifecycle status
- active
- Status basis
- Official initiative launched in 2021 and an HLA-haplobank proof-of-principle was published in 2023.
- Status evidence date
- 2023-12-20
- Scale
- Modeling indicates 13 selected HLA-homozygous lines could match about 30% of Saudis and 39 lines about 50%; current deposited-line count is not stated.
02 / Organizations and population
Who and what the project connects.
- Lead organizations
- King Abdullah International Medical Research Center (KAIMRC)
- Partner organizations
- Ministry of National Guard Health Affairs · Saudi Stem Cell Donor Registry
- Organism / population
- Saudi patients with genetic disorders and healthy HLA-selected donors
03 / Data and access
What exists and how it can be reached.
Data types
- induced pluripotent stem-cell lines
- HLA genotypes
- functional genomics
Data access
Application/controlled cell-bank access; terms on official site
Identifiers
No public accession or identifier is listed for this record.
04 / Evidence and provenance
Why the record is included.
Inclusion basis
Named national cell-bank resource with explicit genomics basis and peer-reviewed population-coverage analysis.
Editorial note
Distinct from, but derived from and linked to, Saudi Stem Cell Donor Registry HLA data.
Sources
- primary record source Verified 2026-08-15
- additional record source Verified 2026-08-15
Release v0.2.0